Fallopian Tube News and Research

RSS
BROCA test identifies 12 gene mutations linked to ovarian and related cancers

BROCA test identifies 12 gene mutations linked to ovarian and related cancers

Caffeine reduces women's chances of becoming pregnant

Caffeine reduces women's chances of becoming pregnant

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer

Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer

Caffeine reduces muscle activity in Fallopian tubes

Caffeine reduces muscle activity in Fallopian tubes

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Study finds more evidence linking high-grade serous ovarian cancer to fallopian tubes

Study finds more evidence linking high-grade serous ovarian cancer to fallopian tubes

Ectopic pregnancies on the rise

Ectopic pregnancies on the rise

Updated NCCN Guidelines for Ovarian Cancer outline new treatment options for women

Updated NCCN Guidelines for Ovarian Cancer outline new treatment options for women

Potential biomarkers for early diagnosis of ectopic pregnancy

Potential biomarkers for early diagnosis of ectopic pregnancy

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

NCI sponsors fourth REOLYSIN clinical trial in pancreatic cancer

How chlamydia increases risk of ectopic pregnancy

How chlamydia increases risk of ectopic pregnancy

Ovarian cancer tissue and healthy tissue smell different

Ovarian cancer tissue and healthy tissue smell different

Oncolytics initiates enrollment in Phase II ovarian cancer study

Oncolytics initiates enrollment in Phase II ovarian cancer study

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Novel serum test may help diagnose early pregnancy location and outcome

Novel serum test may help diagnose early pregnancy location and outcome

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer

GOG to initiate combination elesclomol-paclitaxel Phase 2 clinical trial for ovarian cancer